Design: Tianna Greham
Verdane partners with Clue to accelerate the future of women’s health
We’re proud to kick off 2026 with news that brings us closer to our core mission: to enable a world where women and people with cycles live better.
Verdane – the European specialist growth equity firm with deep expertise in digital health - has invested in us to accelerate the next phase of growth for women’s health. The substantial contribution from Verdane’s €2 billion growth fund is both significant and strategic, and is the single largest in Clue’s history.
The partnership follows an exceptional 2025 that strengthened our growth foundations and created a clear path to long-term and sustainable profitability. It’s a powerful sign of confidence in what we’ve built over the past 13 years, and in our ability to reach women everywhere with trusted, science-based cycle tracking. All without compromising our values.
Our next phase of growth
With Verdane’s partnership, we’ll accelerate growth in these key areas:
Deeper product innovation – Enhancing user experience and feature development
Expanded global reach – Scaling new and existing markets
Healthcare partnerships – Expanding access to personalised care
Clinical research – Investing in world-class research to inform our product excellence and continue to close the women’s health gap
Privacy-first technology – Strengthening market leading privacy and security measures
Personalised care – Investing in technology that delivers more personalised insights
Our shared vision for women’s health
We and Verdane share a belief: women’s health is one of the most underserved – and most impactful – categories in global health and wellness. We both see the opportunity to build category-defining products that combine scientific rigor, ethical data practices, and long-term thinking to deliver meaningful outcomes for our users and society.
We’ve built our reputation on our commitment to medical research, scientific-based insights and leading data privacy standards. Our approach to women’s health is inclusive and goes way beyond fertility tracking alone. Verdane brings deep experience partnering with mission-driven, digital-first companies, helping them scale responsibly while staying true to their values and ethical positioning.
Rhiannon White, CEO at Clue, says: "Women are the world’s largest health and wellness consumers, controlling the majority of household spending in every market, yet they remain strikingly underserved relative to their economic power. This gap creates three systemic pain points: a profound lack of accessible female health knowledge that forces women to self-diagnose, a confusing marketplace filled with unproven products and little evidence-based guidance, and persistent barriers to accessing care.
For businesses, this represents not just a social issue but a significant market failure and a compelling opportunity to build trusted, data driven solutions that meet the needs of the most influential spenders in global health and wellness.
Partnering with Verdane enables us to accelerate the creation of this powerful ecosystem and tackle these issues for women. Verdane’s deep expertise in growing sustainable businesses, combined with their extensive operating experience in the health and wellness space means they bring unparalleled support to the opportunity in front of us.”
Building for sustainable, long-term impact
Verdane’s focus on sustainable growth, operational excellence, and building enduring market leaders aligns closely with our ambition to set the global standard for digital women’s health. Together, we aim to advance the category by investing in research, partnerships, and privacy-first technology.
“We are highly impressed by the Clue management team and the strong momentum the business is demonstrating,” says Christina Stoll, Principal at Verdane. “Clue has earned exceptional user trust by combining the highest data protection standards with rigorous, science-based insights in a category where credibility truly matters. Consumer demand and awareness for trusted women’s health solutions continue to accelerate, and Clue is uniquely positioned to lead this space.
With Verdane’s sector expertise in scaling digital health and wellbeing platforms, we are confident that we can be a strong long-term partner to the team, supporting continued growth, product innovation, and an outstanding user experience, while deepening valuable partnerships across the health and wellbeing ecosystem.
Clue’s women-led, mission-driven approach and focus on meaningful impact strongly align with what Verdane stands for.”
About Verdane
Verdane is a specialist growth buyout investment firm that partners with tech-enabled and sustainable businesses that help to digitalise and decarbonise the European economy. The flexible mandates of Verdane funds allow it to invest as a majority or minority control investor, replacement or growth capital, in single companies or in portfolios of companies.
Verdane has raised over €9 billion in capital and its funds have made more than 200 investments in fast-growing businesses since 2003. Verdane’s team of over 150 investment professionals and operating experts is based out of Berlin, Copenhagen, London, Helsinki, Munich, Oslo and Stockholm, and combines deep sector expertise with long-standing local networks and presence in core European markets.
Verdane is also a certified B Corporation, the most ambitious sustainability accreditation globally. The firm only backs businesses that pass its 2040 test, which indicates whether the company can thrive in a more sustainable future economy.
Verdane is partly owned by the Verdane Foundation, which is focused on two areas: climate change and more equitable and inclusive local communities.
App Store
Play Store
About Clue
Clue is the #1 women-led period and cycle tracker, loved by over 100 million women and people with cycles around the world.
Available in 23 languages and over 190 countries, Clue helps members turn their cycle into a powerful tool to discover patterns, stay on top of changes, and make informed health decisions.
With one of the largest datasets of longitudinal menstrual health information globally, Clue regularly partners with leading research institutions to advance understanding in women’s health and close longstanding data gaps. Clue is committed to empowering people with accurate health information while setting the standard for data privacy, security, and user trust.
